KALA
KALA BIO, Inc.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Mar 4 KALA BIO announced a strategic initiative to become a dedicated AI i…
- Jun 26 ▼ KALA BIO's shelf registration (File No. 333-295667) became effective…
- Jul 22 ▼ KALA BIO filed a 424B5 prospectus supplement for an at-the-market (A…
- Aug 28 ▼ KALA BIO received a delisting notice from Nasdaq on August 27, 2026,…
- Aug 28 Trading halt: Halt Resumed: KALA, trading resumed after LUDP (Volatility…
- Aug 28 Trading halt: Trading Halt: KALA, LUDP (Volatility Trading Pause)
- Aug 31 ▼ Short interest jumps 57.9% to 403.1K
- Sep 24 Contract: Kala Bio and Virotek Sign Letter of Intent with U.S. DNA T…
- Sep 30 ▼ Short interest jumps 205.1% to 1.36M
- Oct 15 ▲ Short interest falls 60.3% to 539.4K
- Oct 30 ▲ Short interest falls 29.0% to 382.8K
- Nov 13 ▼ KALA BIO filed a late notification (NT 10-Q) for its quarterly repor…
Signal stack
Where each data set points today.
- InstitutionsMIXED
Q3 2026: 1 added (0 new), 2 trimmed or exited.
- Short sellersCOVERING
Short interest −29.0% to 382.8K shares. 1.8 days to cover, ≈2.0% of shares.
- TrendDOWNTREND
58% below its 50-day average. New closing low $0.1390 on Nov 13.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| BARCLAYS PLC | NEAR_EXIT | Not reported |
| UBS Group AG | NEAR_EXIT | $577.00 |
| MORGAN STANLEY | DOUBLED | $54.00 |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
Last action Sep 2025| Date | Firm | Rating |
|---|---|---|
| Sep 29, 2025 | HC Wainwright & Co. DOWNGRADE | Neutral |
| Sep 17, 2025 | HC Wainwright & Co. MAINTAIN | Buy |
| Sep 11, 2025 | Oppenheimer MAINTAIN | Outperform |
| Sep 8, 2025 | Mizuho INITIATE | Outperform |
| May 23, 2025 | HC Wainwright & Co. MAINTAIN | Buy |
| Apr 4, 2025 | HC Wainwright & Co. REITERATE | Buy |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | None | None | No data | $0.00 |
| Next Q | None | None | No data | $0.00 |
| Current FY | None | None | No data | $0.00 |
| Next FY | None | None | No data | $0.00 |
Short side
FINRA· Oct 30, 2026| Nov 13, 2026 | Resumption Scheduled | Resumed |
| Aug 28, 2026 | Volatility Pause | Resumed |
SecBot reports
8 filings · 2 press releases · 0 bullish · 5 bearish · 3 neutral- BEARISH NT 10-QNov 13, 2026
KALA BIO filed a late notification (NT 10-Q) for its quarterly report for the period ended…
The pattern of repeated late filings, combined with a $3M market cap and prior asset foreclosure, points to a company that may be unable to continue as a going concern. Monitor for the actual 10-Q…
- BEARISH 8-KNov 12, 2026
KALA BIO filed a Certificate of Amendment to effect a 1-for-30 reverse stock split, reducing…
A 1-for-30 reverse split with authorized shares unchanged at 1.5 billion creates massive potential dilution (over 2,300% of post-split shares). Monitor for subsequent equity offerings or Nasdaq…
- NEUTRAL 8-KNov 9, 2026
KALA BIO reported preliminary Q3 2026 net loss of approximately $0.8 million, a ~90% reduction…
The dramatic reduction in net loss and elimination of debt suggest the company has materially restructured its cost base. The strategic pivot to an AI platform business model introduces significant…
- NEUTRAL SC 13GOct 19, 2026
Nachum Labkowski filed a Schedule 13G disclosing a 5.0% passive stake in KALA BIO, Inc…
A new 5% passive stake by an individual investor is routine and carries no activist intent. Monitor for any subsequent conversion to a 13D or additional share accumulation, which would signal a…
All KALA filing & press-release reports (10)
- NT 10-Q reportNov 13, 2026
- 8-K reportNov 12, 2026
- 8-K reportNov 9, 2026
- SC 13G reportOct 19, 2026
- PRESS-RELEASE reportSep 24, 2026
- 8-K reportAug 28, 2026
- 424B5 reportJul 22, 2026
- EFFECT reportJun 26, 2026
- S-3 reportMay 7, 2026
- PRESS-RELEASE reportMar 4, 2026